RxDoctor Payments Data

Craig Thompson

Medical Oncology · New York, NYNPI 1336180710

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,724,985 of the $4,758,441 with a category attached, or 99.3%. 4 manufacturers reported payments, led by Regeneron at 56.9% of the total. 2025 is the largest year on record at $1,938,269, more than ten times the $23,368 reported in 2019. Among medical oncology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,758,441in general payments, 2019–2025

Across 144 payments — averaging $33,045 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$2.7M
  • Merck$2M
  • Agios Pharmaceuticals, Inc.$59K
  • Abiomed$118

What the payments were for

  • Consulting fees$4,724,98599%
  • Travel & lodging$26,5681%
  • Food & beverage$6,8870%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron130$2,708,149
Merck3$1,990,924
Agios Pharmaceuticals, Inc.10$59,250
Abiomed1$118

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,758,441 in reported general payments places this provider in the 95th percentile of 498 medical oncology providers in New York.

See all medical oncology providers in New York →

Other medical oncology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →